Social Risk Factor Associations With Presenting Visual Acuity in Patients With Microbial Keratitis.
Journal
JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
pmc-release:
15
06
2024
medline:
18
8
2023
pubmed:
15
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
Neighborhood-level social risk factors may contribute to health disparities in microbial keratitis (MK) disease presentation. Understanding neighborhood-level factors may identify areas for revised health policies to address inequities that impact eye health. To investigate if social risk factors were associated with presenting best-corrected visual acuity (BCVA) for patients with MK. This was a cross-sectional study of patients with a diagnosis of MK. Patients presenting to the University of Michigan with a diagnosis of MK between August 1, 2012, and February 28, 2021, were included in the study. Patient data were obtained from the University of Michigan electronic health record. Individual-level characteristics (age, self-reported sex, self-reported race and ethnicity), presenting log of the minimum angle of resolution (logMAR) BCVA, and neighborhood-level factors, including measures on deprivation, inequity, housing burden, and transportation at the census block group, were obtained. Univariate associations of presenting BCVA (< 20/40 vs ≥20/40) with individual-level characteristics were assessed with 2-sample t, Wilcoxon, and χ2 tests. Logistic regression was used to test associations of neighborhood-level characteristics with the probability of presenting BCVA worse than 20/40 after adjustment for patient demographics. A total of 2990 patients with MK were identified and included in the study. Patients had a mean (SD) age of 48.6 (21.3) years, and 1723 were female (57.6%). Patients self-identified with the following race and ethnicity categories: 132 Asian (4.5%), 228 Black (7.8%), 99 Hispanic (3.5%), 2763 non-Hispanic (96.5%), 2463 White (84.4%), and 95 other (3.3%; included any race not previously listed). Presenting BCVA had a median (IQR) value of 0.40 (0.10-1.48) logMAR units (Snellen equivalent, 20/50 [20/25-20/600]), and 1508 of 2798 patients (53.9%) presented with BCVA worse than 20/40. Patients presenting with logMAR BCVA less than 20/40 were older than those who presented with 20/40 or higher (mean difference, 14.7 years; 95% CI, 13.3-16.1; P < .001). Furthermore, a larger percentage of male vs female sex patients presented with logMAR BCVA less than 20/40 (difference, 5.2%; 95% CI, 1.5-8.9; P = .04), as well as Black race (difference, 25.7%; 95% CI, 15.0%-36.5%;P < .001) and White race (difference, 22.6%; 95% CI, 13.9%-31.3%; P < .001) vs Asian race, and non-Hispanic vs Hispanic ethnicity (difference, 14.6%; 95% CI, 4.5%-24.8%; P = .04). After adjusting for age, self-reported sex, and self-reported race and ethnicity, worse Area Deprivation Index (odds ratio [OR], 1.30 per 10-unit increase; 95% CI, 1.25-1.35; P < .001), increased segregation (OR, 1.44 per 0.1-unit increase in Theil H index; 95% CI, 1.30-1.61; P < .001), higher percentage of households with no car (OR, 1.25 per 1 percentage point increase; 95% CI, 1.12-1.40; P = .001), and lower average number of cars per household (OR, 1.56 per 1 less car; 95% CI, 1.21-2.02; P = .003) were associated with increased odds of presenting BCVA worse than 20/40. Findings of this cross-sectional study suggest that in a sample of patients with MK, patient characteristics and where they live were associated with disease severity at presentation. These findings may inform future research on social risk factors and patients with MK.
Identifiants
pubmed: 37318786
pii: 2806092
doi: 10.1001/jamaophthalmol.2023.2415
pmc: PMC10273131
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-734Subventions
Organisme : NIGMS NIH HHS
ID : K12 GM111725
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031033
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB032328
Pays : United States
Organisme : NCATS NIH HHS
ID : UM1 TR004404
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK133226
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031337
Pays : United States
Commentaires et corrections
Type : CommentOn
Références
Health Educ Behav. 2016 Apr;43(2):201-7
pubmed: 26293458
Eye (Lond). 2003 Nov;17(8):957-74
pubmed: 14631403
Ophthalmic Epidemiol. 2022 Jun;29(3):279-285
pubmed: 34139932
Indian J Ophthalmol. 2019 Oct;67(10):1593-1598
pubmed: 31546487
Appl Geogr. 2014 Jan;46:147-157
pubmed: 25404783
Am J Ophthalmol. 2012 Dec;154(6 Suppl):S53-62.e1
pubmed: 23158224
J Gerontol A Biol Sci Med Sci. 2007 Feb;62(2):191-5
pubmed: 17339645
J Ophthalmic Inflamm Infect. 2022 Aug 2;12(1):26
pubmed: 35916989
Soc Sci Med. 2003 Dec;57(11):2023-34
pubmed: 14512234
Surv Ophthalmol. 1989 Jul-Aug;34(1):47-58
pubmed: 2678553
Surv Ophthalmol. 2019 May - Jun;64(3):255-271
pubmed: 30590103
J Glaucoma. 2021 May 1;30(5):369-370
pubmed: 33428354
Ophthalmol Ther. 2022 Aug;11(4):1371-1382
pubmed: 35674883
Cornea. 2006 Feb;25(2):153-8
pubmed: 16371773
Cornea. 2021 Apr;40(4):472-476
pubmed: 33214415
Qual Rep. 2020 Jun;25(6):1473-1488
pubmed: 32924032
Issues Ment Health Nurs. 2001 Oct-Nov;22(7):691-701
pubmed: 11881182
Cornea. 2023 Feb 1;42(2):217-223
pubmed: 36256452
Med Ref Serv Q. 2017 Jul-Sep;36(3):266-272
pubmed: 28714811
Ophthalmol Sci. 2022 Jun;2(2):
pubmed: 35662804
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
Cornea. 2023 Sep 1;42(9):1069-1073
pubmed: 36036690
Curr Opin Ophthalmol. 2017 Jul;28(4):299-304
pubmed: 28379859
Ophthalmology. 2017 Nov;124(11):1678-1689
pubmed: 28942073
Mo Med. 2022 Jan-Feb;119(1):49-54
pubmed: 36033149
West J Nurs Res. 2000 Nov;22(7):796-811
pubmed: 11077548
Eye (Lond). 2016 Mar;30(3):447-55
pubmed: 26634710
Bull World Health Organ. 2001;79(3):214-21
pubmed: 11285665
J Aging Health. 2006 Dec;18(6):852-68
pubmed: 17099137
Ophthalmology. 2004 Jul;111(7):1298-306
pubmed: 15234129
Ophthalmic Epidemiol. 2016 Aug;23(4):257-63
pubmed: 27348134
Milbank Q. 2019 Jun;97(2):407-419
pubmed: 31069864
J Refract Surg. 1997 Jul-Aug;13(4):388-91
pubmed: 9268940
Curr Med Res Opin. 2010 Mar;26(3):683-705
pubmed: 20078320
Ophthalmology. 2017 Oct;124(10):1442-1448
pubmed: 28583710
Health Place. 2017 Jan;43:104-112
pubmed: 28012312
Ophthalmology. 2023 Apr;130(4):404-412
pubmed: 36521570
J Nutr. 2008 Dec;138(12):2428-35
pubmed: 19022968
Br J Ophthalmol. 2019 Jun;103(6):730-736
pubmed: 29970390
J Pharm Policy Pract. 2021 Mar 4;14(1):28
pubmed: 33663583
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:5-8
pubmed: 24385658
Cornea. 2019 Aug;38(8):933-937
pubmed: 31276456
J Gen Intern Med. 2020 May;35(5):1571-1575
pubmed: 32076989
Semin Ophthalmol. 2019;34(3):131-136
pubmed: 30920316
J Epidemiol Community Health. 2014 Mar;68(3):204-10
pubmed: 24179053
Eye (Lond). 2019 Aug;33(8):1224-1231
pubmed: 30858565